Er,Cr:YSGG Laser Application in Peri-implantitis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
In the present study, investigators, aimed to evaluate the effect of erbium, chromium:yttrium-scandium-gallium-garnet (Er,Cr:YSGG) laser application combined with mechanical debridement (MD) on clinical parameters and biochemical parameters such as receptor activator of nuclear factor-kappa B ligand (RANKL) and osteoprotegerin (OPG) in patients with peri-implant diseases.
Epistemonikos ID: 6eb7e7013a5ce2e30b32be08cf75211a123ff20c
First added on: May 15, 2024